Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Nov 27;16(6):1105–1110. doi: 10.4103/1673-5374.300461

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © 2021 Neural Regeneration Research

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

PMC Copyright notice

Effect of myricetin on Fpn1 mRNA (A) and protein (B) expression in rotenone-induced MES23.5 cells.

Cells were pretreated with 1 × 10^–6 M myricetin for 1 hour, followed by co-treatment with 400 nM rotenone for 24 hours. Rotenone treatment downregulated Fpn1 mRNA and protein expression compared with the control. Myricetin prevented induction of Fpn1 mRNA and protein levels by rotenone. Data represent mean ± SD (n = 4 in A, 10 in B). **P < 0.01, ***P < 0.001, vs. control group; ^#P < 0.05, vs. rotenone group (one-way analysis of variance followed by post hoc Tukey’s test). Fpn1: Ferroportin 1; GAPDH: glyceraldehyde 3-phosphate dehydrogenase. Relative mRNA expression of Fpn1 is normalized to that of GAPDH (optical density ratio). Relative protein expression of Fpn1 is expressed as the optical density ratio to β-actin.